Teva among first cleared to launch Abilify generic
WASHINGTON — The Food and Drug Administration has approved the first generic versions of Otsuka Pharmaceutical’s Abilify (aripiprazole), an antipsychotic drug. The FDA said Tuesday that Teva Pharmaceuticals, Alembic Pharmaceuticals, Hetero Labs and Torrent Pharmaceuticals have been cleared to market generic aripiprazole in multiple strengths and dosage forms. With the approval, Teva Pharmaceutical Industries Ltd. on Tuesday announced the U.S.
